Prat 2014 FIGO staging for cancer of the ovary, fallopian tube, and peritoneum as assigned by the caller (IA, IB, IC1-IC3, IIA, IIB, IIIA1i, IIIA1ii, IIIA2, IIIB, IIIC, IVA, IVB). Returns the canonical stage and Prat 2014 defining features. magent does not read imaging or pathology and does not apply AJCC TNM. Not endometrial or cervical FIGO. Not a diagnosis. Not a medical device.

Lindström 2003 Finnish diabetes risk score (FINDRISC). Original seven-item 0–20 score, cutoff ≥9: age (<45 → 0, 45–54 → 2, 55–64 → 3, ≥65 → 4); BMI (<25 → 0, 25–30 → 1, >30 → 3); sex-specific waist; BP medication 2; high-glucose history 5; daily 30-min activity 0 else 2; daily vegetables 0 else 1. Returns score and at_risk. Not a diabetes diagnosis and not the later family-history revision.

Modified Finnegan NAS from Maguire 2013 Table 1 (operational modified FNAS; not a 31-item website variant; not Maguire's 7-item short form). Exclusive cry, sleep, Moro, tremor, fever, respiratory, and stool bands plus true/false CNS, vasomotor, and GI items. Sum 0-46. at_or_above_8 iff score >= 8. magent does not examine the infant. Not Eat Sleep Console. Not a morphine order, diagnosis, or medical device.

Fisher 1980 original CT groups 1-4 for subarachnoid hemorrhage as assigned from CT by the caller. Returns the published group and description. Group 3 (thick SAH) was the high-vasospasm group; group 4 is ICH/IVH without thick SAH, not a worse grade than 3. Not modified Fisher 2006. Not a diagnosis; magent does not read the CT.

Callery 2013 Fistula Risk Score after pancreatoduodenectomy: gland texture firm 0 / soft 2; pathology PDAC or pancreatitis 0 / other (ampullary, duodenal, cystic, islet cell) 1; duct mm ≥5 0, ≥4 1, ≥3 2, ≥2 3, else 4; EBL mL ≤400 0, 401–700 1, 701–1000 2, >1000 3. Max 10. Bands negligible 0, low 1–2, intermediate 3–6, high 7–10. magent does not palpate the gland or measure EBL. Not a CR-POPF diagnosis, not an ISGPS grade, not Ranson or BISAP. Not a medical device.

Merkel 1997 FLACC from five caller-assigned 0-2 items (face, legs, activity, cry, consolability) using that paper's 0/1/2 descriptors. magent sums only (max 10) and does not observe the child. No later intensity cutoffs. Not a pain diagnosis or analgesic order. Not PAINAD.

Flamm 1997 admission VBAC score, max 10. Points: age under 40 (+2); vaginal birth none 0, before first cesarean 1, after first cesarean 2, before and after 4; first cesarean not for failure to progress (+1); admission effacement gt_75 +2, from_25_to_75 +1, lt_25 0; dilation >=4 cm (+1). Published success 49% for scores 0-2 and 95% for 8-10; other scores return the total only. Not a trial-of-labor order. magent does not examine the cervix.

MacMahon 2017 Fleischner table for one solid noncalcified incidental nodule. size_mm 1-30 and caller-assigned high_risk. <6 mm: no routine follow-up (optional CT at 12 months if high risk). 6-8 mm: CT at 6-12 months, then consider or obtain 18-24 month CT by risk. >8 mm: consider CT at 3 months, PET/CT, or tissue sampling. Not subsolid, multiple, or Lung-RADS screening. magent does not read CT. Not a diagnosis or medical device.

Bedogni 2006 fatty liver index from caller-supplied BMI, waist, triglycerides (mg/dL or mmol/L), and GGT. FLI = logistic(L)*100 with L from loge triglycerides, BMI, loge GGT, and waist. FLI <30 rules out hepatic steatosis; FLI >=60 rules in; 30 to <60 indeterminate. Not a diagnosis, imaging substitute, hepatic steatosis index, NAFLD fibrosis score, FIB-4, or APRI.

Solal-Céligny 2004 FLIPI: age >60, Ann Arbor III–IV, hemoglobin <120 g/L, nodal areas >4, LDH above ULN; 1 point each, max 5. Low 0–1, intermediate 2, high ≥3. Deterministic published score with citation; not a follicular-lymphoma diagnosis or treatment choice; FLIPI 2004 not FLIPI-2. magent does not stage lymphoma, assay hemoglobin, count nodal sites, or measure LDH.

Maurer 2025 FLIPI24: 24-month event probability in newly diagnosed follicular lymphoma from age (nonlinear, inflection at 75), hemoglobin, WBC, LDH/ULN, and beta-2 microglobulin. Table S5 Cox algorithm assuming R-CHOP or B-R-like immunochemotherapy and 50% anti-CD20 maintenance. Low/intermediate/high at 0.10 and 0.15. Not Solal-Céligny FLIPI 2004. Not a diagnosis or treatment order. magent does not assay labs.

Net fluid balance in mL: caller-assigned total intake minus total output over the same interval. Optional oral plus IV intake and urine, ultrafiltration, drain, and GI output must sum to those totals when sent (Acheampong and Vincent 2015). Does not estimate insensible losses. Not a resuscitation or diuretic order; magent does not measure I/O. Deterministic published arithmetic with citation.

Tavaglione 2023 fibrotic NASH index (FNI) from AST, HbA1c, and HDL cholesterol. FNI = e^x/(1+e^x) with x = -10.33 + 2.54*ln(AST) + 3.86*ln(HbA1c) - 1.66*ln(HDL mg/dL). HDL may be mg/dL or mmol/L (×38.67). Rule-out ≤0.10; indeterminate between 0.10 and 0.33; rule-in ≥0.33. Not a biopsy, not FIB-4, not the NAFLD fibrosis score, not SAFE, and not BARD.

Adult IV fomepizole milligrams from weight (AACT 1999). Loading 15 mg/kg. Maintenance 10 mg/kg every 12 hours for four doses, then 15 mg/kg every 12 hours after 48 hours (auto-induction). Same milligrams during hemodialysis at a 4-hour interval. Not a prescription, indication, or brand order. magent does not assay ethylene glycol or methanol.

Fong 1999 clinical score after hepatic resection for metastatic colorectal cancer: five caller-assigned preoperative flags (node-positive primary, disease-free interval <12 months, more than one hepatic tumor, largest tumor >5 cm, CEA >200 ng/mL), 1 point each, score 0–5. favorable is true iff score ≤2. Not a resectability decision or adjuvant protocol. magent does not interpret imaging or pathology.

Forrest 1974 endoscopic ulcer class as assigned by the caller: ia active spurting haemorrhage, ib active oozing, iia non-bleeding visible vessel, iib adherent clot, iic flat pigmented haematin / coffee-ground base, iii clean ulcer base. Returns the canonical class and 1974 lesion description. magent does not interpret endoscopy images or invent rebleeding percentages. Not a medical device.

FOUR score (Wijdicks 2005) from caller-assigned eye, motor, brainstem, and respiration integers 0-4; magent sums only (max 16) and does not pick a component from a narrative. Eye 4 tracking/blink to command to 0 closed to pain; motor 4 thumbs-up/fist/peace to 0 none or myoclonus status; brainstem 4 pupil and corneal present to 0 pupil, corneal, and cough absent; respiration 4 not intubated regular to 0 ventilator rate or apnea. Not a diagnosis and not a GCS conversion.

4Ts score (Lo 2006) for heparin-induced thrombocytopenia pretest probability. Four caller-assigned integers 0-2 (thrombocytopenia, timing, thrombosis, other causes) using the published table; magent sums only (max 8). Bands 0-3 low, 4-5 intermediate, and 6-8 high pretest probability. Not a diagnosis of HIT, not the HEP score, and not an antibody result. magent does not grade platelet counts or day of onset.

Black 2001 FRACTURE Index with known total-hip T-score. Age <65 0 through >=85 5. T >= -1 0; -2 <= T < -1 2; -2.5 <= T < -2 3; T < -2.5 4. Fracture after 50, maternal hip after 50, weight <=125 lb, smoker +1 each; arms to stand +2. Max 15. 5-year hip/vertebral/nonvertebral percents from printed quintiles 1-2, 3-4, 5, 6-7, 8-13. Age 18-120; T -5.0 to 4.0. Not a device, not FRAX, not a DXA order. Postmenopausal derivation; magent does not DXA-scan or take a history.

Wilson 1998 Framingham 10-year CHD from sex-specific total-cholesterol point sheets: age 30-74, TC, HDL, JNC-V blood pressure, diabetes, and smoking. Deterministic published arithmetic with citation. Not a statin order, not ATP-III 2001, not pooled-cohort ASCVD. magent does not measure lipids or BP.

McKee 1971 Framingham CHF criteria. Definite if two major, or one major plus two minor, are concurrent. Nine major and seven minor caller-assigned flags. Weight loss ≥4.5 kg in 5 days in response to treatment is dual: major if that is definite, else minor if that is definite, else unused. major_count and minor_count are the fixed flags only. Not a medical device, not an echocardiographic diagnosis, and not HFrEF or HFpEF staging.

Free water deficit from weight, sex, and measured Na using Adrogué–Madias TBW (0.6 male / 0.5 female). Deterministic published arithmetic with citation; not a water-replacement infusion protocol.

Friedewald estimated LDL-C from total cholesterol, HDL, and triglycerides. One unit system (mg/dL or mmol/L). Deterministic published equation with citation; not a diagnosis or statin order.

Fuhrman 1982 nuclear grade for renal cell carcinoma as assigned by the caller (grades 1-4). Returns the grade and the published nuclear-feature description. magent does not read slides. Not WHO/ISUP 2016. Not an RCC diagnosis. Not a medical device.

Rost 2008 FUNC score (0-11) after primary ICH from caller-assigned volume, age, location (lobar/deep/infratentorial), GCS, and pre-ICH cognitive impairment. Volume <30 mL scores 4, 30-60 scores 2, >60 scores 0; age <70 scores 2, 70-79 scores 1, >=80 scores 0; lobar 2, deep 1, infratentorial 0; GCS >=9 scores 2, <=8 scores 0; cognitive impairment absent scores 1. Companion to the Hemphill ICH Score, not a replacement. Not a diagnosis or withdrawal-of-care protocol. magent does not read CT.

Bellera 2012 G8 geriatric screening tool: seven MNA items (A, B, C, E, F, H, P) plus age. Food intake 0–2, weight loss 0–3, mobility 0–2, neuropsychological 0–2, BMI 0–3, more than 3 medications 0 if true else 1, health vs peers 0/0.5/1/2, age 0–2. Total 0–17, higher is better. Score ≤14 is an impaired screen. Not a CGA, chemotherapy order, Soubeyran 2014 ONCODAGE, or VES-13. magent does not interview or weigh the patient.

Spitzer 2006 GAD-7 from seven caller-assigned integers 0-3 (nervous, control worry, worry too much, relaxing, restless, irritable, afraid); magent does not interpret the items. Total 0-21. Cut points 5/10/15 (mild/moderate/severe); 0-4 is below the mild cut (minimal). Returns case_finding_ge_10 (score ≥10; paper sensitivity 89% and specificity 82% for GAD). Not a GAD diagnosis, not a treatment order, not PHQ-9, and not GAD-2.

Forrest 2005 Glasgow alcoholic hepatitis score from age, WBC, urea, PT ratio, and bilirubin (range 5-12) with the published ≥9 band. Deterministic published arithmetic with citation; not a steroid order.

Johnson 2014 GALAD linear predictor from age, sex, AFP ng/mL, AFP-L3 percent, and DCP ng/mL. galad_score = -10.08 + 0.09*age + 1.67*sex + 2.34*log10(AFP) + 0.04*AFP-L3 + 1.33*log10(DCP); sex is 1 if male else 0. Returns galad_score to 2 decimals. Not an HCC diagnosis, listing protocol, probability, or Johnson 2015 ALBI. DCP is ng/mL, not mAU/mL.

Ganzoni 1970 iron deficit: weight_kg * (target_hemoglobin_g_dl - hemoglobin_g_dl) * 2.4 + iron_stores_mg. Deterministic published arithmetic with citation. Not an IV iron product dose or order; magent does not pick target Hb or depot iron, and this is not a diagnosis of iron deficiency.

Ley 2012 GAP index (points) from sex (male 1), age (≤60 → 0, 61–65 → 1, >65 → 2), FVC % predicted (>75 → 0, 50–75 → 1, <50 → 2), and DLCO % predicted (>55 → 0, 36–55 → 1, ≤35 → 2; cannot perform → 3). Returns a 0–8 total and stage 1–3 (0–3 / 4–5 / 6–8). Deterministic published points with citation. Not a transplant listing and not a continuous GAP calculator.

Fox 2017 GARFIELD-AF 1-year all-cause mortality, ischaemic stroke/systemic embolism, and major bleed from age, sex, weight, pulse, diastolic BP, comorbidities, smoking, caller-assigned ethnicity (White/Caucasian reference; Hispanic/Latino, Asian, Black/Mixed/Other), oral anticoagulant class (none, NOAC, VKA), carotid occlusive disease, and antiplatelet therapy. Published 1-year equations. magent does not assign race or ethnicity. Not a diagnosis or anticoagulation order.

Glasgow Coma Scale from eye, verbal, and motor integers. edition=1974 (motor 1-5, max 14) or edition=1976 (motor 1-6, max 15) is required; magent does not pick one. Deterministic published score with citation; not a diagnosis.

GCS-Pupils (GCS-P) as caller-assigned total GCS 3-15 minus pupil reactivity score (unreactive pupils 0, 1, or 2) per Brennan 2018. Returns the index only (GCS-P range 1-15). magent does not examine pupils, assign GCS, compute eye/verbal/motor (use /api/calc/gcs), or implement Part 2 probability charts. Not a medical device and not a TBI-severity diagnosis.

Sheikh 1986 GDS-15: fifteen yes/no items as asked. Reverse-scored (false=1): satisfied_with_life, good_spirits, happy_most_of_time, wonderful_to_be_alive, full_of_energy; other ten score 1 if true. Sum 0-15. No later 0-4/5-9/10+ cutoffs. Not a diagnosis, not PHQ-9, not the 30-item GDS, not a medical device. magent does not interview.

GELF criteria (Brice 1997). High tumor burden in follicular lymphoma if any of eight caller-assigned items: mass >7 cm; ≥3 nodes each >3 cm; B symptoms; spleen below umbilicus; compression; serous effusion; leukemic phase; cytopenia. Any yes is high_burden. Not a treatment order, not FLIPI, not IPI, not modified GELF. magent does not measure nodes, spleen, counts, or effusions.

Chopard 2006 Geneva score for VTE prophylaxis in acutely ill medical inpatients. Eleven 2-point factors plus eight 1-point factors including age >60. Max 30. Score <3 low; >=3 high (prophylaxis indicated). Not a diagnosis or order. Not Revised Geneva PE. Not Padua.

Sperduto 2019 updated GI-GPA: KPS <80 = 0, 80 = 1.0, 90-100 = 2.0; age >=60 = 0, <60 = 0.5; extracranial metastases present = 0, absent = 0.5; number of brain metastases >3 = 0, 2-3 = 0.5, 1 = 1.0. Max 4.0. GPA 0-1.0 / 1.5-2.0 / 2.5-3.0 / 3.5-4.0 median survival 3, 7, 11, 17 months (abstract/KM). Not a treatment order. Not lung-molGPA. magent does not assign KPS.

Gillmore 2018 NAC ATTR cardiac staging from NT-proBNP (ng/L) and caller-assigned eGFR. Stage I: NT-proBNP <=3000 and eGFR >=45. Stage III: NT-proBNP >3000 and eGFR <45. Stage II: exactly one of those two adverse cut points. Returns gillmore_stage 1/2/3. ATTRwt and ATTRv. Not Mayo AL amyloid staging. Not NYHA. Not a treatment order. magent does not compute MDRD or CKD-EPI.

Tefferi 2018 GIPSS for primary myelofibrosis: karyotype (favorable 0, unfavorable 1, VHR 2; caller assigns the three-tier class), absence of type 1/like CALR 1, ASXL1 1, SRSF2 1, U2AF1Q157 1 (not S34); max 6. Low 0, intermediate_1 1, intermediate_2 2, high ≥3. Published median (5-year) survivals 26.4 y (94%), 8.0 y (73%), 4.2 y (40%), 2 y (14%). Not DIPSS or MIPSS70-plus. magent does not karyotype or sequence.

Neonatal glucose infusion rate (GIR, mg/kg/min) from the unit conversion used with AAP 2011 postnatal glucose homeostasis: GIR = (dextrose_percent x rate_ml_h) / (6 x weight_kg), or (dextrose_percent x rate_ml_kg_h) / 6. Provide rate_ml_h plus weight_kg, or rate_ml_kg_h, not both rate styles. Dextrose 2.5-25% and weight 0.4-10 kg are magent clamps, not AAP input bands. Reports GIR only. Does not order dextrose or TPN. Not a medical device.

Glasgow-Blatchford score (Blatchford 2000) for need for treatment after upper-gastrointestinal haemorrhage. Points from urea, haemoglobin (sex-specific), systolic BP, heart rate ≥100, melena, syncope, hepatic disease, and cardiac failure; max 23. Score 0 is the published low-risk screen; magent does not invent other GBS bands. Not a diagnosis, not Rockall, and not AIMS65. Urea may be mmol/L or BUN mg/dL; haemoglobin g/L or g/dL.

Blamey 1984 Glasgow-Imrie eight-factor pancreatitis score: age >55, WBC >15 ×10^9/L, glucose >10 mmol/L, urea >16 mmol/L, PaO2 <60 mm Hg, calcium <2.0 mmol/L, albumin <32 g/L, LDH >600 U/L; 1 point each, max 8. Severe predicted if score ≥3. Caller-assigned flags; magent does not convert units. Not a diagnosis. Not Ranson. Transaminases omitted as in the paper.

Gleason 1974 prostatic adenocarcinoma score from caller-assigned primary pattern 1-5 plus secondary pattern 1-5. Score equals primary plus secondary (range 2-10). magent does not read slides. Not ISUP/Epstein 2016 Grade Groups. Not 2005 ISUP modified pattern rules. Not a diagnosis or treatment recommendation. Not a medical device.

McPherson 2012 GMAWS from five caller-assigned 0-2 items (tremor, sweating, hallucination, orientation, agitation) using that paper's Figure 1 0/1/2 descriptors. magent sums only (max 10) and returns Figure 1 bands zero, 1_to_3, 4_to_8, or 9_to_10. Temperature is not an item. magent does not observe the patient. Not a benzodiazepine or treatment order.

Ebell 2013 GO-FAR integer score for CPC 1 after in-hospital CPR. Exclusive age (<70=0, 70-74=2, 75-79=5, 80-84=6, >=85=11) plus 12 caller-assigned flags (intact CPC 1 at admission -15; trauma 10; stroke 8; cancer 7; septicemia 7; medical noncardiac 7; hepatic 6; SNF 6; hypotension 5; renal 4; respiratory 4; pneumonia 1). Range -15 to 76. Bands: >=24 very_low, 14-23 low, -5 to 13 average, <=-6 above_average. Not GO-FAR 2. Not a DNAR order.

GOLD 2017 spirometric grade (Vogelmeier executive summary). Post-bronchodilator FEV1/FVC < 0.70 defines obstruction; then GOLD 1 if FEV1 % predicted >= 80, GOLD 2 if 50 to <80, GOLD 3 if 30 to <50, GOLD 4 if <30. Ratio >= 0.70 returns not_obstructed even when FEV1 is low. Not GOLD ABE (no mMRC, CAT, or exacerbations). magent does not perform spirometry. Not a medical device or a diagnosis.

Janssens 2010 diagnostic rule for acute gouty arthritis without joint fluid: male 2, previous arthritis attack 2, onset within 1 day 0.5, joint redness 1, MTP1 2.5, hypertension or CVD 1.5, uric acid >5.88 mg/dL or >350 µmol/L 3.5; max 13. Low ≤4, intermediate 4.5–7.5, high ≥8. uric_acid_mg_dl or uric_acid_umol_l, not both. Deterministic published score; not a gout diagnosis; magent does not examine joints or replace synovial crystal analysis.

Forrest 2003 original Glasgow Prognostic Score (GPS) from CRP in mg/L and albumin. Elevated CRP is >10 mg/L; hypoalbuminaemia is albumin <35 g/L. Assign 1 for CRP >10 and 1 for albumin <35, then sum: GPS 0 when CRP ≤10 and albumin ≥35; GPS 1 when CRP ≤10 and albumin <35 (isolated hypoalbuminaemia) or CRP >10 and albumin ≥35; GPS 2 when CRP >10 and albumin <35. Not mGPS, not hs-mGPS, not a cancer diagnosis or treatment order. magent does not assay CRP or albumin.

Granger 2003 in-hospital GRACE 1.0: integer nomogram points from age, heart rate, systolic BP, creatinine (mg/dL or µmol/L), Killip class 1-4, cardiac arrest, ST-segment deviation, and elevated initial enzymes. Total 1-372. In-hospital mortality percent is that paper's printed score readout. Not GRACE 2.0, not Fox 2006 6-month, not ESC 108/140 cutoffs. Not a medical device and not a cath-lab order.